August 8, 2020 | Karen Hardin, IFA Contributing Writer
Question #1: If hydroxychloroquine is harmful, why is it a key ingredient in the vaccine?
Question #2: Why did a company valued at just over 300 million dollars receive a “loan” from the government for $765 million to work on the Covid-19 vaccine?
Question #3: IF you were going to pump $765 million dollars into a facility to create the vaccine, why would you choose a company known for film and cameras rather than a seasoned vaccine maker?
These are just a few of the questions that have emerged after it was reported that International Development Finance Corporation (DFC) loaned Kodak $765 million dollars for pharmaceutical development of the Covid-19 vaccine using the Defense Production Act, turning Kodak into a pharmaceutical company. President Trump called it “one of the most important deals in the history of US pharmaceutical industries.”
Just prior to the announcement on July 28, the stock was around $2.50/share. But over the next 48 hours, it jumped 2757%. Kodak CEO Jim Continenza received stock options on July 27, a day before the loan announcement. Those options are now reportedly worth over $79 million according to the New York Times.
Interestingly, NBC News reported in December 2019 a few billionaire investors bought millions of low-cost shares, buying more than 27% of the company. One was Kodak board director George Karfunkel. In 2009, Bill Gates was a 5% owner in Kodak. How much did he own as of December 2019? The NBC report listing the billionaires has since been removed from the internet.
The Securities and Exchange Commission has questions as well and are reportedly investigating how Eastman Kodak received this loan and the subsequent trading that followed.
But there’s more.
What do you think is the truth? Discuss and share with your friends . . .
According to an insider working with the manufacturer producing the API’s (Active Pharmaceutical Ingredient) for the vaccine for Kodak, the manufacturing plant is now being used exclusively on the production of these API’s. One of which is the generic version of hydroxychloroquine (HCQ). So, if HCQ is ineffective or even dangerous as the American public is now being told by the CDC, then why is it a key ingredient in this vaccine?
What is behind this Kodak company odd loan? Is this coming from President Trump because he knows hydroxychloroquine works and is pressing past the CDC? Or are the players behind Kodak the ones telling us it doesn’t work, but who are in fact stockpiling it now for the upcoming vaccine?
The benefits of hydroxychloroquine, according to doctors who are using it effectively, is that it is most effective in the early onset of the virus. So, if we are being tested for the virus and show a positive result, what is the drug that they should be utilizing to flatten the curve? Hydroxychloroquine.
Prior to the COVID-19 outbreak, 10 companies were approved by the FDA to manufacture various generic versions of hydroxychloroquine. One of these was Apotex, Inc. a Canadian pharmaceutical corporation founded in 1974 by Barry Sherman. The company eventually became one of the largest producers of generic drugs in Canada. However, in December 2017, Sherman and his wife, Honey, were murdered and their bodies left in a “creepy” position similar to life size statues sitting behind them. Their murders remain unsolved as does the question: was it related to their ownership of the HCQ generic drug that was growing in demand by those who were already working on a vaccine?
So now it is revealed that hydroxychloroquine (or its generic version) is a key ingredient in the COVID vaccine. What else do we know about the vaccine? We do know that a coronavirus vaccine was started as early as June 2015 by The Pirbright Institute, whose website gives “primary funder” status to Bill & Melinda Gates. Their application for a patent for the live coronavirus was approved on Nov 20, 2018.
In the end there are still more questions than answers regarding this drug and who is behind these new developments.
Let us press in to pray for truth.
Karen Hardin is an intercessor, author, minister, and literary agent. Her work has appeared on USA Today, World Net Daily, Intercessors for America, Charisma, CBN.com, The Elijah List, etc. For additional information, you can contact her at www.prioritypr.org or www.karenhardin.com. (Photo from Dreamstime.)